HYCOFENIX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hycofenix, and when can generic versions of Hycofenix launch?
Hycofenix is a drug marketed by Chartwell Rx and is included in one NDA.
The generic ingredient in HYCOFENIX is guaifenesin; hydrocodone bitartrate; pseudoephedrine hydrochloride. There are twenty drug master file entries for this compound. Additional details are available on the guaifenesin; hydrocodone bitartrate; pseudoephedrine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HYCOFENIX?
- What are the global sales for HYCOFENIX?
- What is Average Wholesale Price for HYCOFENIX?
Summary for HYCOFENIX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for HYCOFENIX |
| DailyMed Link: | HYCOFENIX at DailyMed |
US Patents and Regulatory Information for HYCOFENIX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Rx | HYCOFENIX | guaifenesin; hydrocodone bitartrate; pseudoephedrine hydrochloride | SOLUTION;ORAL | 022279-001 | May 14, 2015 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
